Three-year safety observation of subcutaneous administration of epoetin-zeta in patients with chronic renal anemia: Results from PASCO II study

Epoetin has been used to treat patients with renal anemia since 1988. Anti-erythropoietin antibody-mediated pure red cell aplasia (PRCA) has been associated with epoetin usage, and a PRCA incidence of 4.5 per 10,000 patient-years was observed for epoetin-α (Eprex) in 2002. The PASCO II study (post-a...

Descripción completa

Detalles Bibliográficos
Autores principales: Patsialas, Stavros, Fowler, Heather, Guilatco, Ruffy, Salts, Stephanie, Xia, Feng Richard, Gomez Perez, Sonja, Iwanowitsch, Andreas, Kohnle, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dustri-Verlag Dr. Karl Feistle 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112001/
https://www.ncbi.nlm.nih.gov/pubmed/36871229
http://dx.doi.org/10.5414/CN110825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112001/
https://www.ncbi.nlm.nih.gov/pubmed/36871229
http://dx.doi.org/10.5414/CN110825

Ejemplares similares